Clinical Trial: Comparative Study of Xiaojiyin Combined with Immunotherapy and Chemotherapy versus Immunotherapy and Chemotherapy Alone in Patients with Advanced Non-Small Cell Lung Cancer and Exploration of Related Biomarkers (China)

Posted On: 2026-08-24

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparative Study of Xiaojiyin Combined with Immunotherapy and Chemotherapy versus Immunotherapy and Chemotherapy Alone in Patients with Advanced Non-Small Cell Lung Cancer and Exploration of Related Biomarkers'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130668

Registration Time: 2026/08/23

Type: Interventional study

Primary Sponsor: Guangdong Provincial Hospital of Chinese Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=208471

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Comparative Study of Xiaojiyin Combined with Immunotherapy and Chemotherapy versus Immunotherapy and Chemotherapy Alone in Patients with Advanced Non-Small Cell Lung Cancer and Exploration of Related Biomarkers (China)